Coloplast
886.8
DKK
-0.31 %
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
4 following
-0.31%
+1.72%
-3.82%
+8.38%
+14.87%
+12.45%
-15.82%
+11.6%
+1,790.83%
investor.coloplast.com/investor-relations
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Revenue
27.03B
EBIT %
27.08 %
P/E
39.48
Dividend yield-%
2.48 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
COLO B
Daily low / high price
884.2 / 895.2
DKK
Market cap
202.37B DKK
Turnover
137.85M DKK
Volume
155K
Financial calendar
General meeting
2024-12-05
Half year dividend
2024-12-06
Interim report
2025-02-04
Interim report
2025-04-06
Interim report
2025-08-19
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Niels Peter Louis-Hansen | 20.7 % | 41.1 % |
| Aage og Johanne Louis-Hansens Fond | 11.5 % | 15.2 % |
| Benedicte Fund | 3.7 % | 5.4 % |
ShowingAll content types
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy
Coloplast A/S - Notice of Annual General Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools